Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Loss of PTEN Regulator Linked to Cancer

By Biotechdaily staff writers
Posted on 25 Jun 2003
A recent study describes the electrostatic mechanism that controls the binding of the tumor-suppressing protein PTEN (phosphatase and tensin homolog on chromosome 10) to the cell membrane.

PTEN is a tumor suppressor that reverses the action of phosphoinositide 3-kinase by catalyzing the removal of the 3' phosphate of phosphoinositides. More...
"The role of PTEN is to counterbalance the action of an enzyme that induces cell growth,” explained senior author Dr. Wonhwa Cho, professor of chemistry at the University of Chicago (IL, USA; www.uic.edu). "Overactivation of the enzyme can lead to cancer. So if you lose a PTEN gene and its cellular activity, the cell goes out of control. It is like a car with an accelerator but without the brakes.”

The investigators employed surface plasmon resonance analysis and cellular microscopic analysis of green fluorescence protein-labeled PTEN to study its transport and binding within the cell. They found that phosphorylation of PTEN changed its electrostatic property. Once it switched from being electrostatically neutral to being positively charged, PTEN attached to negatively charged molecules on the cell membrane. These findings were published June 13, 2003, in the online edition of the Proceedings of the National Academy of Science.

Mutations resulting in the loss of PTEN regulation have been linked to various cancers, including glioblastoma, endometrial carcinoma, and a cancer-prone condition called Cowden disease.

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.